SYRE Stock Analysis Today
Updated Nov 12, 2026 · trends, key levels, insider activity and news
Is SYRE bullish or bearish today?
Daily trend: Uptrend (starting) — turns down below $76.87
SEPT signal: Accumulation · Strong Bullish
Research grade: B · fair value $117.50 (+10.0%)
SYRE trend by timeframe
| Daily | Uptrend (starting) |
|---|---|
| 4 hour | Strong Bullish |
| 1 hour | Strong Bullish |
| 15 min | Symmetric Triangle |
| 5 min | Strong Bullish |
Trends are calculated from price structure and update during market hours.
SYRE support and resistance levels
Resistance (above)
$110.172 touches
$145.501 touches
$168.501 touches
Support (below)
$100.424 touches
$92.779 touches
$86.624 touches
Upside zones: $98.44 / $101.62 / $104.80
See all levels on the live chart →Insider and institutional activity
Insiders
Sell30-day buys / sells
0 / 730-day net
—Hedge fund holders
240Latest SYRE news and filings
- AnalystFiscal.ai
Wedbush keeps Outperform on Spyre Therapeutics, cuts price target
Wedbush repeated its Outperform rating on Spyre Therapeutics while lowering its price target. The change reflects the analyst's updated view of the stock.
- AnalystBenzinga
Guggenheim keeps Buy rating on Spyre Therapeutics, lifts target to $135
Guggenheim reiterated its Buy rating on Spyre Therapeutics and raised its price target to $135. The update reflects the firm's current view on the stock.
- AnalystBenzinga
Wedbush keeps Outperform rating on Spyre Therapeutics, cuts target to $120
Wedbush reiterated an Outperform rating on Spyre Therapeutics while reducing its price target to $120. The change reflects the firm's updated view on the stock.
- EarningsFiscal.ai
Spyre Therapeutics Posts Q3 2026 Results, Issues Business Update
The biotech company released its quarterly financial figures for the period ended in 2026 and shared an update on its operations. No specific numbers or details were included in the headline.
- SEC FilingSECSpyre Therapeutics, Inc. filed a report on a major company event (Form 8-K)
Form 8-K tells shareholders about important events such as deals, leadership changes or results.
Live SYRE chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is SYRE bullish or bearish today?
SYRE daily trend: Uptrend (starting) — turns down below $76.87. SEPT signal: Accumulation (Strong Bullish). Updated Nov 12, 2026.
What is SYRE's trend on each timeframe?
Daily: Uptrend (starting); 4 hour: Strong Bullish; 1 hour: Strong Bullish; 15 min: Symmetric Triangle; 5 min: Strong Bullish.
What are SYRE support and resistance levels?
Support: $100.42, $92.77, $86.62. Resistance: $110.17, $145.50, $168.50. Last price $106.82.
Are insiders buying or selling SYRE?
Insider signal: Sell. Last 30 days: 0 buys, 7 sells. 240 hedge funds hold SYRE.
What is the latest news on SYRE?
Nov 4, 2026: Wedbush keeps Outperform on Spyre Therapeutics, cuts price target · Nov 4, 2026: Guggenheim keeps Buy rating on Spyre Therapeutics, lifts target to $135 · Nov 4, 2026: Wedbush keeps Outperform rating on Spyre Therapeutics, cuts target to $120